This statistic shows the amount funded by the top public funders for research and development on neglected diseases worldwide in 2023. The United States is constantly the biggest public funder. In that specific year, the U.S. was responsible for around 1.96 billion U.S. dollars in public funding for R&D on neglected diseases. Public funding for neglected diseases R&DThe United States contributes a large portion of global public funding for research and development on neglected diseases, totaling around two billion U.S. dollars out of a total 2.6 billion in 2023. The European Union contributed a total of 187 million U.S. dollars. Many people in the world’s low-income countries suffer from neglected diseases. These diseases are a significant source of disability and mortality in these regions, and many suffer from more than one disease simultaneously. The Gates Foundation is the largest philanthropic funder of R&D for neglected diseases worldwide, funding 775 million U.S. dollars in 2023. This foundation is one of the largest private foundations in the world and was launched in 2000. Its headquarter is located in Seattle, Washington. As for neglected diseases, the foundation aims to reduce the burden of disease through effective control, elimination, and eradication efforts.

This data package contains dataset on prevalence rates of health conditions and diseases like obesity, diabetes and hearing loss and health risk factors for diseases like tobacco, alcohol and drug use.

This statistic displays the percentage of the U.S. adult population that has been diagnosed with infectious diseases and those self-reporting the condition as of 2019, and the gender distribution. As of that year, 14 percent of the adult population reported that they had a infectious disease. Of these, more than two thirds were women.

It is estimated that around nine percent of the population in the United States has been diagnosed with an infectious disease. Infectious diseases are caused by bacteria, viruses and other organisms and can be spread from person to person, through insect or animal bites, or through contaminated food or water. Some of the most common infectious diseases include HIV/AIDS, influenza, malaria, tuberculosis and hepatitis.

HIV/AIDS

HIV/AIDS is one of the most well-known infectious diseases worldwide. There are currently almost 38 million people worldwide living with HIV and it is responsible for just under a million deaths per year. HIV treatment has improved dramatically over the last few decades but access to treatment varies. The poorer regions of the world still suffer disproportionately from HIV with the majority of those infected living in Africa.

Tuberculosis

Like HIV/AIDS, tuberculosis also impacts the poorer regions of the world more than developed nations. Tuberculosis impacts the lungs of those infected and is currently the tenth leading cause of death worldwide. The countries with the highest incidence rates of tuberculosis include India, China, Indonesia, and the Philippines. In India alone tuberculosis was responsible for around 440,000 deaths in 2018.

These data represent prevalence estimates of select infectious diseases from the National Health and Nutrition Examination Survey (NHANES).

BackgroundThe prospect of eliminating onchocerciasis from Africa by mass treatment with ivermectin has been rejuvenated following recent successes in foci in Mali, Nigeria and Senegal. Elimination prospects depend strongly on local transmission conditions and therefore on pre-control infection levels. Pre-control infection levels in Africa have been mapped largely by means of nodule palpation of adult males, a relatively crude method for detecting infection. We investigated how informative pre-control nodule prevalence data are for estimating the pre-control prevalence of microfilariae (mf) in the skin and discuss implications for assessing elimination prospects.Methods and FindingsWe analyzed published data on pre-control nodule prevalence in males aged ≥20 years and mf prevalence in the population aged ≥5 years from 148 African villages. A meta-analysis was performed by means of Bayesian hierarchical multivariate logistic regression, accounting for measurement error in mf and nodule prevalence, bioclimatic zones, and other geographical variation. There was a strong positive correlation between nodule prevalence in adult males and mf prevalence in the general population. In the forest-savanna mosaic area, the pattern in nodule and mf prevalence differed significantly from that in the savanna or forest areas.SignificanceWe provide a tool to convert pre-control nodule prevalence in adult males to mf prevalence in the general population, allowing historical data to be interpreted in terms of elimination prospects and disease burden of onchocerciasis. Furthermore, we identified significant geographical variation in mf prevalence and nodule prevalence patterns warranting further investigation of geographical differences in transmission patterns of onchocerciasis.

BackgroundEstimating the burden of healthcare-associated infections (HAIs) compared to other communicable diseases is an ongoing challenge given the need for good quality data on the incidence of these infections and the involved comorbidities. Based on the methodology of the Burden of Communicable Diseases in Europe (BCoDE) project and 2011–2012 data from the European Centre for Disease Prevention and Control (ECDC) point prevalence survey (PPS) of HAIs and antimicrobial use in European acute care hospitals, we estimated the burden of six common HAIs.Methods and FindingsThe included HAIs were healthcare-associated pneumonia (HAP), healthcare-associated urinary tract infection (HA UTI), surgical site infection (SSI), healthcare-associated Clostridium difficile infection (HA CDI), healthcare-associated neonatal sepsis, and healthcare-associated primary bloodstream infection (HA primary BSI). The burden of these HAIs was measured in disability-adjusted life years (DALYs). Evidence relating to the disease progression pathway of each type of HAI was collected through systematic literature reviews, in order to estimate the risks attributable to HAIs. For each of the six HAIs, gender and age group prevalence from the ECDC PPS was converted into incidence rates by applying the Rhame and Sudderth formula. We adjusted for reduced life expectancy within the hospital population using three severity groups based on McCabe score data from the ECDC PPS. We estimated that 2,609,911 new cases of HAI occur every year in the European Union and European Economic Area (EU/EEA). The cumulative burden of the six HAIs was estimated at 501 DALYs per 100,000 general population each year in EU/EEA. HAP and HA primary BSI were associated with the highest burden and represented more than 60% of the total burden, with 169 and 145 DALYs per 100,000 total population, respectively. HA UTI, SSI, HA CDI, and HA primary BSI ranked as the third to sixth syndromes in terms of burden of disease. HAP and HA primary BSI were associated with the highest burden because of their high severity. The cumulative burden of the six HAIs was higher than the total burden of all other 32 communicable diseases included in the BCoDE 2009–2013 study. The main limitations of the study are the variability in the parameter estimates, in particular the disease models’ case fatalities, and the use of the Rhame and Sudderth formula for estimating incident number of cases from prevalence data.ConclusionsWe estimated the EU/EEA burden of HAIs in DALYs in 2011–2012 using a transparent and evidence-based approach that allows for combining estimates of morbidity and of mortality in order to compare with other diseases and to inform a comprehensive ranking suitable for prioritization. Our results highlight the high burden of HAIs and the need for increased efforts for their prevention and control. Furthermore, our model should allow for estimations of the potential benefit of preventive measures on the burden of HAIs in the EU/EEA.

In Mexico, the prevalence of hypercholesterolemia in adults reached a 30.4 percent in 2023. Kidney disease was the second-most common chronic disease reported, with 20.7 percent respondents indicating that they had been diagnosed with the condition. Meanwhile, 17.4 percent of interviewees received a High blood pressure diagnosis.

These data represent prevalence estimates of select infectious diseases from the National Health and Nutrition Examination Survey (NHANES). This version of the NHANES dataset is specific to visualization within the NCHS DQS. Search, visualize, and download these and other estimates from over 120 health topics with the NCHS Data Query System (DQS), available from: https://www.cdc.gov/nchs/dataquery/index.htm.

In 2019/20, approximately 31 percent of men and 37 percent of women in England reported to suffer from allergies. Furthermore, depression affected around 17 percent of women and 12 percent of men.

These data contain case counts and rates for selected communicable diseases—listed in the data dictionary—that met the surveillance case definition for that disease and was reported for California residents, by disease, county, year, and sex. The data represent cases with an estimated illness onset date from 2001 through the last year indicated from California Confidential Morbidity Reports and/or Laboratory Reports. Data captured represent reportable case counts as of the date indicated in the “Temporal Coverage” section below, so the data presented may differ from previous publications due to delays inherent to case reporting, laboratory reporting, and epidemiologic investigation.

This dataset, released January 2020, contains for the time period of 2017-2018 the Estimated population, aged 18 years and over with diabetes mellitus; Estimated male population with mental and behavioural problems; Estimated female population with mental and behavioural problems; Estimated population with mental and behavioural problems; Estimated population with heart, stroke and vascular disease; Estimated population with asthma; Estimated population with chronic obstructive pulmonary disease; Estimated population with arthritis; Estimated population with osteoporosis; The data is by Local Government Area (LGA) 2016 geographic boundaries. For more information please see the data source notes on the data. Source: Estimates for Population Health Areas (PHAs) are modelled estimates and were produced by the ABS; estimates at the LGA and PHN level were derived from the PHA estimates. AURIN has spatially enabled the original data. Data that was not shown/not applicable/not published/not available for the specific area ('#', '..', '^', 'np, 'n.a.', 'n.y.a.' in original PHIDU data) was removed.It has been replaced by by Blank cells. For other keys and abbreviations refer to PHIDU Keys.

Snapshot img

Infectious Disease Diagnostics Market Size 2024-2028

The infectious disease diagnostics market size is forecast to increase by USD 8.90 billion at a CAGR of 4.5% between 2023 and 2028. The market is witnessing substantial growth, driven by several key factors. The increasing prevalence of infectious diseases worldwide continues to fuel market expansion. According to the World Health Organization, infectious diseases account for approximately 15 million deaths annually, making them a significant global health concern. Moreover, the development of novel drugs and treatments is another significant growth driver. These advancements offer improved diagnostic accuracy and effectiveness, addressing the unmet needs of healthcare providers and patients. Additionally, the increasing adoption of Point-of-Care (POC) diagnostics is transforming the market landscape. POC testing enables rapid, on-site diagnosis, providing immediate results and improving patient outcomes. This trend is particularly prominent in resource-limited settings and emergency care, where quick diagnosis is crucial. The market's growth is further influenced by a transition towards more efficient systems, better accessibility, and higher industry standards. As the demand for advanced solutions grows, companies in this sector are prioritizing sustainability and operational efficiency to maintain a competitive edge.

What will be the size of the market during the forecast period?

Request Free Sample

Infectious Disease Diagnostics Market Segmentation

The infectious disease diagnostics market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018 - 2022 for the following segments.

End-user

  Hospitals
  Labs


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

Which is the largest segment driving market growth?

The hospitals segment is estimated to witness significant growth during the forecast period.

The market is experiencing substantial growth due to the rising prevalence of diseases such as HIV, tuberculosis (TB), hepatitis, sexually transmitted infections (STIs), respiratory infections, and other infectious diseases. According to the World Health Organization, there are approximately 50,733 hospitals worldwide, and the number continues to grow. Hospitals procure medical testing kits, consumables, software, and services in large quantities from suppliers and group purchasing organizations (GPOs), driving market expansion. Clinical laboratories and urgent care centers are significant consumers of infectious disease diagnostic tools, with skilled technicians and physicians performing tests on samples such as blood, urine, mucus, and respiratory secretions.

Infectious diseases, including HIV, pneumonia, and hospital-acquired infections, require prompt diagnosis and infection control measures to prevent cross contamination and ensure personal health. Technological advancements in next-generation sequencing, genomic testing, molecular testing, and immunodiagnostics are enhancing pathogen detection capabilities, enabling rapid results and reducing false negatives and positives. The market encompasses a range of diagnostic devices, assays and reagents, and information technology systems, catering to various applications, including chest X-rays, CT scans, physical exams, and PCR testing. Infections caused by bacteria, viruses, fungi, and parasites continue to pose significant health risks, necessitating ongoing research and development In the market.

Get a glance at the market share of various regions. Download the PDF Sample

The Hospitals segment was valued at USD 23.83 billion in 2018 and showed a gradual increase during the forecast period.

Which region is leading the market?

Asia is estimated to contribute 43% to the growth of the global market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.The market in North America is driven by the increasing prevalence of infectious diseases, including HIV, tuberculosis (TB), hepatitis, sexually transmitted infections (STIs), and respiratory infections. According to the Centers for Disease Control and Prevention (CDC), respiratory tract infections caused by bacteria are among the most common conditions, affecting approximately 85 million Americans each year. These infections result in significant economic burden due to healthcare costs and lost productivity. In the US, infectious diseases such as AIDS, TB, meningitis, influenza, and pneumonia are major health concerns. The market growth is further fueled by the need for prompt

These data represent prevalence estimates of select chronic conditions from the National Health and Nutrition Examination Survey (NHANES).

The Study of Health in Pomerania (SHIP) is a population-based epidemiological project consisting of three independent cohorts (SHIP-START, SHIP-TREND, and SHIP-NEXT).

The SHIP project has two main objectives:

1. to assess prevalence and incidence of common risk factors, subclinical disorders, and clinical diseases; and
2. to investigate the complex associations among risk factors, subclinical disorders, clinical diseases, and the consequences of diseases.

A particular characteristic of SHIP is that it does not focus on a selected disease; it rather attempts to describe health-related conditions with the widest possible focus using highly innovative non-invasive methods. Important medical areas of research include cardiovascular diseases, diabetes mellitus, liver and biliary tract diseases, neurological diseases, thyroid diseases, dental diseases, lung diseases, addiction, and risk behaviour.

This statistic shows the prevalence rate of selected rare diseases companies worldwide in 2017. As of that year, the prevalence rate of multiple sclerosis was 90 per 100,000 worldwide.

Qatar QA: Cause of Death: by Communicable Diseases & Maternal, Prenatal & Nutrition Conditions: % of Total data was reported at 5.200 % in 2016. This records a decrease from the previous number of 5.300 % for 2015. Qatar QA: Cause of Death: by Communicable Diseases & Maternal, Prenatal & Nutrition Conditions: % of Total data is updated yearly, averaging 5.400 % from Dec 2000 (Median) to 2016, with 4 observations. The data reached an all-time high of 8.800 % in 2000 and a record low of 5.200 % in 2016. Qatar QA: Cause of Death: by Communicable Diseases & Maternal, Prenatal & Nutrition Conditions: % of Total data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Qatar – Table QA.World Bank.WDI: Health Statistics. Cause of death refers to the share of all deaths for all ages by underlying causes. Communicable diseases and maternal, prenatal and nutrition conditions include infectious and parasitic diseases, respiratory infections, and nutritional deficiencies such as underweight and stunting.; ; Derived based on the data from WHO's Global Health Estimates.; Weighted average;

IMPORTANT NOTE #####From October 2024, this project is being updated by Dr. Juan Armando Torres Munguía. In case of questions, requests, or collaborations, you can contact me via GitHub, X, or here. You can access the updated data here: https://github.com/jatorresmunguia/disease_outbreak_news

Dengue has been a major public health concern in Australia since it re-emerged in Queensland in 1992–1993. We explored spatio-temporal characteristics of locally-acquired dengue cases in northern tropical Queensland, Australia during the period 1993–2012.

Locally-acquired notified cases of dengue were collected for northern tropical Queensland from 1993 to 2012. Descriptive spatial and temporal analyses were conducted using geographic information system tools and geostatistical techniques.

This figure is a bar graph plotting dengue incidence rates by age and gender in northern Queensland, Australia, 1993–2012.

IntroductionSouth Africa has the largest burden of HIV worldwide and has a growing burden of non-communicable diseases; the combination of which may lead to diseases clustering in ways that are not seen in other regions. This study sought to identify common disease classes and sociodemographic and lifestyle factors associated with each disease class.MethodsData were analyzed from the South African Demographic and Health Survey 2016. A latent class analysis (LCA) was conducted using nine disease conditions. Sociodemographic and behavioral factors associated with each disease cluster were explored. All analysis was conducted in Stata 15 and the LCA Stata plugin was used to conduct the latent class and regression analysis.ResultsMultimorbid participants were included (n = 2 368). Four disease classes were identified: (1) HIV, Hypertension and Anemia (comprising 39.4% of the multimorbid population), (2) Anemia and Hypertension (23.7%), (3) Cardiovascular-related (19.9%) and (4) Diabetes and Hypertension (17.0%). Age, sex, and lifestyle risk factors were associated with class membership. In terms of age, with older adults were less likely to belong to the first class (HIV, Hypertension and Anemia). Males were more likely to belong to Class 2 (Anemia and Hypertension) and Class 4 (Diabetes and Hypertension). In terms of alcohol consumption, those that consumed alcohol were less likely to belong to Class 4 (Diabetes and Hypertension). Current smokers were more likely to belong to Class 3 (Cardiovascular-related). People with a higher body mass index tended to belong to Class 3 (Cardiovascular-related) or the Class 4 (Diabetes and Hypertension).ConclusionThis study affirmed that integrated care is urgently needed, evidenced by the largest disease class being an overlap of chronic infectious diseases and non-communicable diseases. This study also highlighted the need for hypertension to be addressed. Tackling the risk factors associated with hypertension could avert an epidemic of multimorbidity.